Surgical vacuum filter-derived stromal cells are superior in proliferation to human bone marrow aspirate.


Journal

Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581

Informations de publication

Date de publication:
21 11 2019
Historique:
received: 21 08 2019
accepted: 18 10 2019
revised: 16 10 2019
entrez: 23 11 2019
pubmed: 23 11 2019
medline: 22 7 2020
Statut: epublish

Résumé

During joint replacement, surgical vacuum suction guarantees a sufficient overview on the situs. We assume high concentrations of mesenchymal stromal cells (MSCs) on surgical vacuum filters. We compared the in vitro proliferative and differentiation potency of cells from the following: (i) bone marrow (BM), (ii) cancellous bone (CB), (iii) vacuum filter (VF), and (iv) cell saver filtrate reservoir (SF) in 32 patients undergoing elective total hip replacement. Mononuclear cells (MNC) were isolated, and cell proliferation and colony-forming units (CFU) were measured. Adherent cells were characterized by flow cytometry for MSC surface markers. Cells were incubated with osteogenic, adipogenic, and chondrogenic stimuli. Cells were cytochemically stained and osteoblastic expression (RUNX-2, ALP, and BMP-2) investigated via qPCR. Dependent on the source, initial MNC amount as well as CFU number was significantly different whereas generation time did not vary significantly. CFU numbers from VF were superior to those from SR, BM, and CB. The resulting amount of MSC from the respective source was highest in the vacuum filter followed by reservoir, aspirate, and cancellous bone. Cells from all groups could be differentiated into the three mesenchymal lines demonstrating their stemness nature. However, gene expression of osteoblastic markers did not differ significantly between the groups. We conclude that surgical vacuum filters are able to concentrate tissue with relevant amounts of MSCs. A new potent source of autologous regeneration material with clinical significance is identified. Further clinical studies have to elucidate the regenerative potential of this material in an autologous setting.

Sections du résumé

BACKGROUND
During joint replacement, surgical vacuum suction guarantees a sufficient overview on the situs. We assume high concentrations of mesenchymal stromal cells (MSCs) on surgical vacuum filters. We compared the in vitro proliferative and differentiation potency of cells from the following: (i) bone marrow (BM), (ii) cancellous bone (CB), (iii) vacuum filter (VF), and (iv) cell saver filtrate reservoir (SF) in 32 patients undergoing elective total hip replacement.
METHODS
Mononuclear cells (MNC) were isolated, and cell proliferation and colony-forming units (CFU) were measured. Adherent cells were characterized by flow cytometry for MSC surface markers. Cells were incubated with osteogenic, adipogenic, and chondrogenic stimuli. Cells were cytochemically stained and osteoblastic expression (RUNX-2, ALP, and BMP-2) investigated via qPCR.
RESULTS
Dependent on the source, initial MNC amount as well as CFU number was significantly different whereas generation time did not vary significantly. CFU numbers from VF were superior to those from SR, BM, and CB. The resulting amount of MSC from the respective source was highest in the vacuum filter followed by reservoir, aspirate, and cancellous bone. Cells from all groups could be differentiated into the three mesenchymal lines demonstrating their stemness nature. However, gene expression of osteoblastic markers did not differ significantly between the groups.
CONCLUSION
We conclude that surgical vacuum filters are able to concentrate tissue with relevant amounts of MSCs. A new potent source of autologous regeneration material with clinical significance is identified. Further clinical studies have to elucidate the regenerative potential of this material in an autologous setting.

Identifiants

pubmed: 31753037
doi: 10.1186/s13287-019-1461-0
pii: 10.1186/s13287-019-1461-0
pmc: PMC6868799
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

338

Références

Braz J Anesthesiol. 2016 May-Jun;66(3):276-82
pubmed: 27108825
Can J Physiol Pharmacol. 2012 Nov;90(11):1434-45
pubmed: 23181272
Egypt J Immunol. 2014;21(1):27-37
pubmed: 25204042
Transfusion. 2016 May;56(5):1112-20
pubmed: 26898972
Sci Rep. 2017 Apr 27;7:46731
pubmed: 28447618
Cytotherapy. 2005;7(5):393-5
pubmed: 16236628
Clin Orthop Relat Res. 1998 Oct;(355 Suppl):S73-81
pubmed: 9917628
Vet Comp Orthop Traumatol. 2013;26(1):34-41
pubmed: 23171924
Injury. 2007 Mar;38 Suppl 1:S26-32
pubmed: 17383482
Orthopade. 2010 Apr;39(4):449-62; quiz 463
pubmed: 20182700
Cytotherapy. 2013 Jun;15(6):641-8
pubmed: 23570660
Stem Cell Res Ther. 2016 Jul 07;7(1):88
pubmed: 27388156
Int Orthop. 2012 May;36(5):1087-94
pubmed: 22012572
Cytotherapy. 2013 Sep;15(9):1054-61
pubmed: 23602578
Histol Histopathol. 2017 Oct;32(10):977-985
pubmed: 28328009
Bone. 2008 Sep;43(3):434-9
pubmed: 18547890
Proteomics Clin Appl. 2019 Mar;13(2):e1800168
pubmed: 30770655
Cell Prolif. 2011 Oct;44(5):428-40
pubmed: 21951286
World J Stem Cells. 2015 Mar 26;7(2):470-6
pubmed: 25815130
Int Orthop. 2014 Jan;38(1):13-8
pubmed: 24077886
J Bone Joint Surg Am. 2005 Jul;87(7):1430-7
pubmed: 15995108
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
J Am Acad Orthop Surg. 2019 Jan 15;27(2):e50-e63
pubmed: 30300216
Tissue Eng Part C Methods. 2013 Dec;19(12):911-24
pubmed: 23537352
Clin Orthop Relat Res. 1990 Mar;(252):156-62
pubmed: 2105869
Cell Stem Cell. 2016 Aug 4;19(2):154-157
pubmed: 27374789
Biomed Khim. 2008 Mar-Apr;54(2):192-200
pubmed: 18522221
J Knee Surg. 2018 Jul;31(6):551-556
pubmed: 28738432
J Cell Biochem. 1997 Feb;64(2):295-312
pubmed: 9027589
Stem Cells. 2015 Jan;33(1):146-56
pubmed: 25187512
Bone. 2018 Apr;109:61-64
pubmed: 29305336
Injury. 2015 Dec;46 Suppl 8:S23-32
pubmed: 26747914
Transfus Med. 2005 Feb;15(1):13-8
pubmed: 15713124
Pak J Pharm Sci. 2017 Nov;30(6):2321-2327
pubmed: 29175805
Neurosci Behav Physiol. 2006 Oct;36(8):841-5
pubmed: 16964461
Orthop Surg. 2017 Feb;9(1):13-19
pubmed: 28276640
Curr Stem Cell Res Ther. 2017;12(5):365-376
pubmed: 25670062
Semin Cell Dev Biol. 2009 Aug;20(6):665-73
pubmed: 19146967
Cytotherapy. 2009;11(4):377-91
pubmed: 19568970
Injury. 2005 Dec;36(12):1392-404
pubmed: 16102764
J Transl Med. 2019 Jan 5;17(1):10
pubmed: 30611285
In Vitro Cell Dev Biol Anim. 1993 Sep;29A(9):699-707
pubmed: 8407713
Stem Cell Res Ther. 2019 Jul 29;10(1):223
pubmed: 31358046
PLoS One. 2014 Sep 19;9(9):e106903
pubmed: 25238158
Biomaterials. 2010 Jan;31(2):270-8
pubmed: 19783038
Knee Surg Sports Traumatol Arthrosc. 2017 Sep;25(9):2957-2966
pubmed: 27085359
Stem Cell Res Ther. 2017 Dec 6;8(1):275
pubmed: 29208029

Auteurs

Katharina Henze (K)

Department of Orthopaedics and Trauma Surgery, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Monika Herten (M)

Department of Orthopaedics and Trauma Surgery, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Marcel Haversath (M)

Department of Orthopaedics and Trauma Surgery, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

André Busch (A)

Department of Orthopaedics and Trauma Surgery, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Sven Brandau (S)

Department of Otorhinolaryngology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Alexander Hackel (A)

Department of Otorhinolaryngology, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Stefanie B Flohé (SB)

Department of Orthopaedics and Trauma Surgery, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.

Marcus Jäger (M)

Department of Orthopaedics and Trauma Surgery, University Hospital Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany. marcus.jaeger@uni-due.de.
Department of Orthopaedics, Trauma and Reconstructive Surgery, University of Duisburg Essen & St. Marien Hospital Mülheim an der Ruhr / Contilia, Kaiserstrasse 50, 45468, Mülheim/Ruhr, Germany. marcus.jaeger@uni-due.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH